dr. julie gralow discusses the swog s0500 trial
Published 10 years ago • 488 plays • Length 2:40Download video MP4
Download video MP3
Similar videos
-
1:15
dr. gralow discusses toxicities experienced in the swog s0307 trial
-
2:08
targeted breast cancer treatment, dr. julie gralow
-
1:13
dr. julie gralow discusses t-dm1-induced thrombocytopenia
-
12:27
julie r. gralow, md: swog so226 trial and bisphosphonates update
-
1:07
dr. julie gralow: exercise is medicine
-
8:13
sjöberg prize 2020
-
1:14:37
immunotherapy and gist
-
22:33
telomere dysfunction and stem cell aging - zhenyu ju
-
16:11
dr. julie r. gralow discusses findings from the rxponder study released at sabcs 2020
-
2:11
dr. julie gralow on treating breast cancer bone metastases
-
3:34
julie gralow, md, provides details on the swog s0226 findings presented at sabcs 2020
-
2:01
dr. gralow on the use of bisphosphonates in early-stage breast cancer
-
1:27
dr. julie gralow on the importance of genetic testing for breast cancer
-
7:42
julie r. gralow, md: new endocrine therapy for metastatic breast cancer
-
1:57
dr. gralow on adjuvant bisphosphonates for breast cancer
-
10:31
julie r. gralow, md: the atlas trial. tamoxifen for five years or ten years?
-
5:35
dr. julie gralow: clinical trials need flexibility, diversity, patient-focus, and ease
-
1:56
dr. gralow on future research into bisphosphonates in breast cancer
-
6:03
julie r. gralow, md: blood clotting issues and tamoxifen
-
5:07
julie gralow, md, summarizes the rxponder trial from the 2020 san antonio breast cancer symposium
-
8:27
julie r. gralow, md: cognitive function and breast cancer
-
2:51
sanofi – smoldering disease in multiple sclerosis